Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

StemCyte to Celebrate 20th Anniversary as a Renowned Leader in the Cord Blood Banking Industry with Grand Open House

Posted on: 18 Sep 17
StemCyte to Celebrate 20th Anniversary as a Renowned Leader in the Cord Blood Banking Industry with Grand Open House Featuring Guest Appearance by PBS KIDS character Daniel Tiger

PR Newswire

BALDWIN PARK, Calif., Sept. 18, 2017

BALDWIN PARK, Calif., Sept. 18, 2017 /PRNewswire/ -- This Spring StemCyte will mark its 20th anniversary as a global leader in the cord blood therapeutic industry. To honor all of its incredible accomplishments of the past 20 years, StemCyte will host a "Grand Open House" celebration at the company's Baldwin Park, CA Headquarters on October 21, 2017 from 10:00 a.m. to 2:00 p.m.

Expectant parents, existing clients and the prestigious group of doctors and staff that StemCyte has worked with through the years, are welcome to attend the event. Guests will enjoy complimentary food, beverages, 4D sonograms and a special guest appearance by PBS KIDS character Daniel Tiger, as seen on PBS SoCal KOCE.

"I would like to take this opportunity to thank all of those who have played a role in our success and all those who we have been privileged to serve for the last 20 years," said Jonas Wang, StemCyte's CEO and Chairman. "We have remained committed to our core values, and we look forward to working together for many more years to come."

About StemCyte
StemCyte's rich history started with a mission of being dedicated to helping the world's physicians save more lives by providing high quality, safe and effective stem cell transplantation and therapy to all patients in need. Located in the US, India and Taiwan, StemCyte has supplied over 2100 cord blood products for over 40 life-threatening diseases to over 300 leading worldwide transplant centers.  StemCyte is actively involved in the development of stem cell therapies. StemCyte was the first to donate umbilical cord blood units (UCB) to Dr. Jaing of Chung Gung Memorial Hospital for his clinical trial to use UCB to treat and cure Beta Thalassemia.  More excitingly is the work and accomplishments of Prof Wise Young, MD, PhD.  Prof. Young has completed Phase II clinical trials on patients with chronic spinal cord injury with UCB and the results are extremely encouraging. StemCyte is chosen by the US Department of Health and Human Services to help establishing a public National Cord Blood Inventory. Its headquarters are located in Baldwin Park, CA.  To learn more visit

Media Contact: 626-646-2500


View original content:


PR Newswire

Last updated on: 18/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.